Adalta Ltd has released a press release.
Cellular immunotherapy manufacturer secured - Cell Therapies
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AdAlta
- Extension of Victorian Government RDTI Loan Facility
- Institutional investment to pursue strategic initiatives
- SYNBV MoU Webinar presentation
- SYNThesis BioVentures MoU for cellular immunotherapies
- Corporate Presentation
Later from AdAlta
- $1.9 million raised from exercise of 1ADOA options
- Transaction, investment facility update
- FY24 RDTI Refund Received $1.77m
- AD-214 clinical advisory board
- East to West cell therapy strategy update
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta